
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
View Full LandscapeTarget Indication
Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy
Clinical Trial
NCT06122389Last updated: 1/7/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.